Tumor-infiltrating lymphocytes in melanoma
S Lee, K Margolin - Current oncology reports, 2012 - Springer
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
treatment for patients with metastatic melanoma. With higher response rates than ipilimumab …
Tumor-infiltrating lymphocyte therapy in melanoma: facts to the future
A Betof Warner, PG Corrie, O Hamid - Clinical Cancer Research, 2023 - AACR
Adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) is gaining momentum and
demonstrating durable responses in patients with advanced melanoma. Although …
demonstrating durable responses in patients with advanced melanoma. Although …
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
S Klobuch, TTP Seijkens, TN Schumacher… - Nature Reviews …, 2024 - nature.com
Immunotherapy with immune-checkpoint inhibitors (ICIs) and targeted therapy with BRAF
and MEK inhibitors have revolutionized the treatment of melanoma over the past decade …
and MEK inhibitors have revolutionized the treatment of melanoma over the past decade …
[HTML][HTML] Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma
MW Rohaan, TH Borch, JH Van Den Berg… - New England journal …, 2022 - Mass Medical Soc
Background Immune checkpoint inhibitors and targeted therapies have dramatically
improved outcomes in patients with advanced melanoma, but approximately half these …
improved outcomes in patients with advanced melanoma, but approximately half these …
[HTML][HTML] Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
MHG Foppen, M Donia, IM Svane, J Haanen - Molecular oncology, 2015 - Elsevier
Over the past few years melanoma incidence has been rising steadily, resulting in an
increase in melanoma related mortality. Until recently, therapeutic options for metastatic …
increase in melanoma related mortality. Until recently, therapeutic options for metastatic …
TIL therapy: facts and hopes
TJ Monberg, TH Borch, IM Svane, M Donia - Clinical Cancer Research, 2023 - AACR
After a positive phase III trial, it is evident that treatment with tumor-infiltrating lymphocytes
(TIL) is a safe, feasible, and effective treatment modality for patients with metastatic …
(TIL) is a safe, feasible, and effective treatment modality for patients with metastatic …
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook
Immunotherapy using autologous T cells has emerged to be a powerful treatment option for
patients with metastatic melanoma. These include the adoptive transfer of autologous tumor …
patients with metastatic melanoma. These include the adoptive transfer of autologous tumor …
Combination of ipilimumab and adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic melanoma
JE Mullinax, ML Hall, S Prabhakaran, J Weber… - Frontiers in …, 2018 - frontiersin.org
Purpose Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma can be highly effective, but attrition due to progression before TIL administration …
melanoma can be highly effective, but attrition due to progression before TIL administration …
[HTML][HTML] Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
JH van den Berg, B Heemskerk… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Abstract Treatment of metastatic melanoma with autologous tumor infiltrating lymphocytes
(TILs) is currently applied in several centers. Robust and remarkably consistent overall …
(TILs) is currently applied in several centers. Robust and remarkably consistent overall …
[HTML][HTML] Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
AH Kverneland, CA Chamberlain… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has
shown remarkable results in malignant melanoma (MM), while studies on the potential in …
shown remarkable results in malignant melanoma (MM), while studies on the potential in …